SomaLogic, Inc.
SLGC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $2 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 19.7% | 46.1% | 73.6% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 55.6% | 59% | 59.5% | -54.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -180% | -105.4% | -56.4% | -148.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -111.8% | -105.7% | -127.7% | -177.1% |
| EPS Diluted | -0.59 | -0.63 | -0.39 | -0.31 |
| % Growth | 6.3% | -61.5% | -25.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |